Table 2.
Parameter | N = 219 | |
---|---|---|
Country, n (%) | ||
UK | 18 | (8.2%) |
Ireland | 22 | (10.0%) |
Germany | 71 | (32.4%) |
Austria | 3 | (1.4%) |
Belgium | 4 | (1.8%) |
The Netherlands | 68 | (31.1%) |
Denmark | 12 | (5.5%) |
Switzerland | 16 | (7.3%) |
Other | 5 | (2.3%) |
Sex, n (%) | ||
Female | 198 | (90.4%) |
Age (years), n (%) | ||
≤ 30 | 49 | (22.4%) |
31–40 | 78 | (35.6%) |
41–50 | 64 | (29.2%) |
> 50 | 28 | (12.8%) |
Race, n (%) | ||
White or Caucasian | 205 | (93.6%) |
Asian | 3 | (1.4%) |
Black or African American | 0 | – |
Other | 11 | (5.0%) |
Occupational status, n (%) | ||
Full time employed | 87 | (39.7%) |
Part time employed | 51 | (23.3%) |
Student | 10 | (4.6%) |
Not working or unemployed | 31 | (14.2%) |
Retired | 40 | (18.3%) |
Highest level of education, n (%) | ||
Primary or elementary school | 7 | (3.2%) |
Secondary or high school | 120 | (54.8%) |
College or university degree | 73 | (33.3%) |
Other | 19 | (8.7%) |
Disease duration, (years), mean (SD) | 10.70 | (9.8) |
Disease duration, n (%) | ||
0–3 | 66 | (30.1%) |
4–10 | 69 | (31.5%) |
11–20 | 51 | (23.3%) |
> 20 | 33 | (15.1%) |
Severity of HS (by Hurley classification) | ||
Mild | 13 | (5.9%) |
Moderate | 132 | (60.3%) |
Severe | 74 | (33.8%) |
Treatment experience | ||
Previous biologic therapy | 65 | (29.7%) |
Previous wide excisional surgery | 134 | (61.2%) |
Level of pain (0–10 VAS), median (IQR) | 5 | 3-7 |
HiSQOL score, median (SD) | ||
Total score | 34 | (16.1) |
Symptom subscale | 8 | (4.1) |
Psychosocial subscale | 10 | (5.5) |
Activities and adaptations subscale | 17 | (8.1) |
EQ-5D-5L, mean (SD) | ||
Mobility | 2.14 | (1) |
Self-care | 1.50 | (0.7) |
Usual activities | 2.21 | (0.9) |
Pain and discomfort | 2.94 | (1) |
Anxiety and depression | 2.58 | (1.2) |
EQ-5D-5L EuroQoL 5-Dimension-5 Level Questionnaire, HiSQOL Hidradenitis Suppurativa Quality of Life Questionnaire, HS hidradenitis suppurativa, IQR interquartile range, SD standard deviation, VAS Visual Analog Scale